Fundies.
English

Segment disclosures

Company overview

Orchestra BioMed Holdings, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 31 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Partnership Revenue · Single Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=obio:PartnershipRevenueMember;us-gaap:StatementBusinessSegmentsAxis=obio:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3132871000 USD20260312Open filing evidence
2025-07-01 – 2025-09-30721000 USD20261110Open filing evidence
2025-01-01 – 2025-09-302120000 USD20261110Open filing evidence
2025-04-01 – 2025-06-30667000 USD20260810Open filing evidence
2025-01-01 – 2025-06-301399000 USD20260810Open filing evidence
2025-01-01 – 2025-03-31732000 USD20260512Open filing evidence
2024-01-01 – 2024-12-312005000 USD20260312Open filing evidence
2024-07-01 – 2024-09-30803000 USD20251110Open filing evidence
2024-01-01 – 2024-09-301928000 USD20251110Open filing evidence
2024-04-01 – 2024-06-30628000 USD20250812Open filing evidence
2024-01-01 – 2024-06-301125000 USD20250812Open filing evidence
2024-01-01 – 2024-03-31497000 USD20250512Open filing evidence
2023-01-01 – 2023-12-312106000 USD20250331Open filing evidence

Product · Single Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=obio:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3091000 USD20261110Open filing evidence
2026-01-01 – 2026-09-30289000 USD20261110Open filing evidence
2026-04-01 – 2026-06-3088000 USD20260810Open filing evidence
2026-01-01 – 2026-06-30198000 USD20260810Open filing evidence
2026-01-01 – 2026-03-31110000 USD20260512Open filing evidence
2025-01-01 – 2025-12-31611000 USD20260312Open filing evidence
2025-07-01 – 2025-09-30140000 USD20261110Open filing evidence
2025-01-01 – 2025-09-30445000 USD20261110Open filing evidence
2025-04-01 – 2025-06-30169000 USD20260810Open filing evidence
2025-01-01 – 2025-06-30305000 USD20260810Open filing evidence
2025-01-01 – 2025-03-31136000 USD20260512Open filing evidence
2024-01-01 – 2024-12-31633000 USD20260312Open filing evidence
2024-07-01 – 2024-09-30184000 USD20251110Open filing evidence
2024-01-01 – 2024-09-30457000 USD20251110Open filing evidence
2024-04-01 – 2024-06-30150000 USD20250812Open filing evidence
2024-01-01 – 2024-06-30273000 USD20250812Open filing evidence
2024-01-01 – 2024-03-31123000 USD20250512Open filing evidence
2023-01-01 – 2023-12-31654000 USD20250331Open filing evidence